Lifesci Capital Comments on Tourmaline Bio FY2024 Earnings
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Lifesci Capital issued their FY2024 earnings estimates for Tourmaline Bio in a research report issued on Monday, February 24th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings of ($2.89) per share for the year. Lifesci Capital has a “Outperform” rating and a $58.00 […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Lifesci Capital issued their FY2024 earnings estimates for Tourmaline Bio in a research report issued on Monday, February 24th. Lifesci Capital analyst R. Katkhuda forecasts that the company will post earnings of ($2.89) per share for the year. Lifesci Capital has a “Outperform” rating and a $58.00 […]
